Stanley C. Erck
2014
In 2014, Stanley C. Erck earned a total compensation of $3.1M as President and CEO at Novavax.
Compensation breakdown
| Non-Equity Incentive Plan | $304,844 |
|---|---|
| Option Awards | $2,280,780 |
| Salary | $487,750 |
| Other | $7,650 |
| Total | $3,081,024 |
Erck received $2.3M in option awards, accounting for 74% of the total pay in 2014.
Erck also received $304.8K in non-equity incentive plan, $487.8K in salary and $7.7K in other compensation.
Rankings
In 2014, Stanley C. Erck's compensation ranked 2,953rd out of 13,032 executives tracked by ExecPay. In other words, Erck earned more than 77.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,953 out of 13,032 | 77th |
Division Manufacturing | 1,047 out of 4,967 | 79th |
Major group Chemicals And Allied Products | 337 out of 1,690 | 80th |
Industry group Drugs | 262 out of 1,369 | 81st |
Industry Biological Products, Except Diagnostic Substances | 41 out of 241 | 83rd |
Source: SEC filing on April 28, 2017.
Erck's colleagues
We found four more compensation records of executives who worked with Stanley C. Erck at Novavax in 2014.